|
|
|
|
|
|
|
||
Original Article |
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Key Words: gene-targeted mice • signal transduction • Itk • Rlk/Txk • T cell receptor
Several models have been put forth to account for how these distinct selection processes result from signals from the same receptor (for review see reference 1). One model suggests that the strength of the signal generated through the TCR in developing thymocytes affects the development of the T cell repertoire. Strong signals that result from high affinity or avidity interactions between the TCR and MHC plus peptide lead to negative selection and death, presumably because these types of signals arise from self-antigens present in the thymus. Intermediate or weak signals from the TCR result in survival and maturation (positive selection) of cells that will expand and populate the periphery. Thus, signals that fail to effectively activate peripheral cells can promote development of thymocytes. Absent or minimal signals, such as when cells express a TCR that does not interact with the appropriate MHC, lead to death by neglect.
Alternatively, other models suggest that specific molecules influence selection choices 1. According to this view, qualitative differences in signaling could account for choices between positive and negative selection processes. For example, expression of dominant-negative mitogen-activated protein (MAP) and extracellular signal–regulated kinase (ERK) kinase (MEKK) or Ras mutants alter positive but not negative selection, suggesting that activation of specific downstream molecules may contribute to selection decisions in the thymus 23. However, as different molecules downstream of the TCR may be activated by different thresholds of signaling, the two above models may not be mutually exclusive.
The Tec kinases comprise the second largest family of nonreceptor tyrosine kinases with several members expressed specifically in cells of the hematopoietic lineages 4. Mutations of the Tec family kinase Bruton's tyrosine kinase (Btk) are associated with a profound B cell immunodeficiency, X-linked agammaglobulinemia (XLA), with defective B cell development and Ig secretion resulting from impaired signaling from surface IgM 56. In T cells, at least three Tec kinases are expressed: Tec, a widely expressed kinase, and resting lymphocyte kinase (Rlk)/Txk and inducible T cell kinase (Itk), which have expression primarily restricted to the T cell lineage and mast cells. Despite the profound B cell developmental block observed in patients with XLA and a milder block in B cell development in the corresponding mutant xid mice, mice with mutations of Rlk/Txk or Itk still develop near normal numbers of T cells 78. In rlk–/– mice, T cell numbers and patterns are similar to wild-type (WT) mice 7. Targeted disruption of itk leads to only mild reductions in T cell numbers, preferentially affecting the CD4 subset, so that a decreased CD4/CD8 ratio is observed 78.
To address the function and possible redundancy of Tec family kinases in T cells, we generated double knockouts of Rlk/Txk and Itk. These mice still develop mature T cells, but when compared with cells from either rlk–/– or itk–/– mice, rlk–/–itk–/– T cells respond very poorly to TCR stimulation 7. Despite more severe defects in TCR-induced proliferation and cytokine production, rlk–/–itk–/– mice have increased mature T cell numbers compared with Itk-deficient mice. Nonetheless, they maintain a decreased CD4/CD8 cell ratio, suggesting that rlk–/–itk–/– thymocytes may undergo altered developmental processes.
To examine T cell development in mice deficient in Tec family kinases, we have evaluated thymic development using TCR-transgenic mice and an in vitro model of deletion. We demonstrate here that mutation of these Tec family kinases alters both positive and negative selection. The reduction in both positive and negative selection and the decreased CD4/CD8 ratio correlate with decreased biochemical parameters of TCR signaling, including defects in capacitive Ca2+ influx and ERK activation. Our results suggest that alterations in TCR signaling resulting from mutation of Tec kinases may change both thymic selection and lineage commitment by altering thresholds for selection and implicate Tec kinases as key modulators of TCR signaling required for normal thymic development.
Antibodies and Reagents.
Flow Cytometry.
Proliferation Assays.
Cell Death Assays.
Immunoprecipitation and Western Blotting.
Ca2+ Mobilization.
Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Development of a proper immune system requires the selection of lymphocytes expressing a useful repertoire of antigen receptors that can respond to foreign or dangerous antigens but not to self. For T cells developing in the thymus, these selection processes include both positive and negative selection of immature CD4+CD8+ cells, helping shape the mature T cell repertoire. These processes are thought to be regulated in large part through the interactions between the TCR expressed on a given thymocyte and peptides presented in the context of either class I or II MHC molecules (for review see reference 1).
Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Mice.
rlk–/–, itk–/–, and rlk–/–itk–/– mice were previously described. itk–/– mice were a gift from Dr. D. Littman (New York University, New York, NY). Mice used in this study had been backcrossed to C57Bl6/J for four generations and were maintained in sterile isolator cages on autoclaved food and water. HY and AND transgenic mice on a C57Bl/6 (H-2b) background were a gift of Dr. B.J. Fowlkes (National Institute of Allergy and Infectious Diseases, Bethesda, MD). rlk–/–itk–/– mice were interbred with TCR-transgenic mice, and the F1 progeny were interbred to generate transgene-positive mice in the control, rlk–/–, itk–/–, and rlk–/–itk–/– backgrounds.
Antibodies for flow cytometry were obtained from PharMingen unless otherwise noted. The following reagents were gifts from the people noted in parentheses: FITC-conjugated T3.70 directed against the HY clonotypic TCR (Dr. E.W. Shores, Food and Drug Administration, Bethesda, MD); anti-CD28 ascites (Drs. J. Powell and R. Schwartz, National Institute of Allergy and Infectious Diseases, Bethesda, MD); anti-CD8
(83-125; Dr. A. Singer, National Cancer Institute, Bethesda, MD); growth factor receptor–bound protein (GRB)-2–glutathione-S-transferase (GST) protein fusion constructs (Dr. R. Wange, National Institute of Aging, Baltimore, MD); anti–Zap-70 and TCR-
antibodies (Dr. L. Samelson, National Cancer Institute, Bethesda, MD); and HY peptide (Dr. M. Vacchio, National Cancer Institute, Bethesda, MD). Antibodies directed against Vav, Cbl, and ERK 1 and 2 were obtained from Santa Cruz Biotechnology, Inc., antiactive ERK antibodies were from Promega and Santa Cruz Biotechnology, Inc., antiphosphotyrosine (4G10) and anti–phospholipase C (PLC)-
1 (mixed monoclonal) were from Upstate Biotechnology, and anti–phospho-p38 was from New England Biolabs, Inc.
Individual cells were prepared from thymi and stained and analyzed by flow cytometry on a FACScanTM (Becton Dickinson) as previously described 7.
Single-cell suspensions were prepared from spleens of HY-transgenic mice. Red blood cells were lysed in ammonium chloride and then resuspended at 106 per milliliter in the presence of varying numbers of WT irradiated splenocytes incubated with 10 µM HY peptide (KCSRNRGYL). 48 h later, cells were pulsed with [3H]thymidine and harvested after 8 h.
Individual thymocyte suspensions were plated at 106 in 1 ml of RPMI plus 10% FCS, with 2 mM glutamine, penicillin/streptomycin, and 2-ME on 24-well plates coated with either 10 µg/ml 2C11 and 10 µg/ml hamster IgG, 10 µg/ml anti-CD28, and 10 µg/ml hamster IgG or both 10 µg/ml 2C11 and anti-CD28. Alternatively anti-CD28 ascites were used at a 1:500 dilution. Control plates were coated with hamster IgG at 10 µg/ml. Cells were incubated at 37°C in 5% CO2 for 18–24 h and then harvested, stained with anti-CD4 and CD8, and analyzed in the presence of 50 µg/ml propidium iodide (PI). Live cells were collected for a constant time. In other experiments, CD4+CD8+ double-positive (DP) cells were enriched by panning twice on anti-CD8–coated plates. After panning, cells were 90–95% DP CD4+CD8+ cells. 2 x 106 cells were incubated in 500 µl on a 24-well plate coated with antibodies as above, harvested 16–24 h later, stained with anti-CD4, CD8, TCR-β, and PI at 66 ng per 106 cells, and washed one time before analysis. In these experiments, absolute numbers of live cells recovered were calculated based on the number of live cells (excluding trypan blue) and flow cytometry profiles.
Individual cell preparations were resuspended in serum-free media and stimulated on plates coated with 3 µg/ml 2C11 for varying times. Alternatively, cells were incubated with biotinylated 2C11 and streptavidin (Sigma-Aldrich) and lysed after indicated times. Cells were either lysed in 2x protein sample buffer (2% SDS, 0.1 M Tris, pH 6.8, 20% glycerol) for examination of total tyrosine phosphorylation or alternatively in an equal volume of 1% SDS, and then diluted 10-fold with 1% Triton X-100 in PBS with protease inhibitors (Roche Molecular Biochemicals) and sodium orthovanadate for immunoprecipitations. Lysates were clarified by centrifugation and then incubated with the appropriate antibodies for 3–12 h. Protein A–Sepharose or antimouse Sepharose beads were added for 1 h and then collected by centrifugation. Beads were washed three times in 0.5% Triton X-100 in PBS containing protease inhibitors and sodium orthovanadate and then resuspended in protein sample buffer and separated on 10% Tris–glycine gels, transferred to nitrocellulose, and immunoblotted with appropriate antibodies. For affinity precipitations, 25 µl of glutathione beads bound to GRB-2–GST fusion protein were incubated with cell lysates for 2–4 h and then washed and analyzed as above.
Individual cells were isolated and then labeled with Fluo-3 AM and Fura-Red AM (Molecular Probes) for 30 min. Cells were washed and held in the dark and then resuspended in PBS with Ca2+ either in the absence or presence of 2 mM EGTA. Baseline Ca2+ measurements were recorded, and then cells were stimulated with either biotinylated 2C11 followed by streptavidin or by thapsigargan. Measurements were recorded for at least 10 min and analyzed with Multitime Software (Pheonix Flow Systems).
Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Altered Thymocyte Populations in itk–/– and rlk–/–itk–/– Mice.
To evaluate the roles of Tec family kinases in T cell developmental processes, we examined populations of thymocytes from mice deficient in Rlk, Itk, or both Tec family kinases. Staining with anti-CD4 and -CD8 indicated that rlk–/– mice have apparently normal thymocyte populations, whereas itk–/– mice have mildly decreased thymic cellularity (Table ; reference 8). In particular, there are decreased numbers of CD4+ single-positive (SP) mature cells with increased numbers of CD8+ SP mature cells in itk–/– mice, so that an altered CD4/CD8 ratio is observed (Fig. 1). Surprisingly, despite their more severe defects in TCR-induced responses in mature T cells, rlk–/–itk–/– mice exhibit increased thymic cellularity relative to itk–/– mice. However, rlk–/–itk–/– thymocytes still have decreased CD4/CD8 ratios similar to that observed in itk–/– mice. Thus, although they exhibit decreased numbers of CD4+ cells, both itk–/– and rlk–/–itk–/– mice have increased total numbers of CD8+ SP cells compared with WT animals.
|
|
Decreased Positive Selection.
The altered patterns of mature cell populations combined with the increased numbers of mature T cells in rlk–/–itk–/– compared with the itk–/– animals suggested that processes of T cell development may be distinct in mice deficient in these kinases. To examine processes of thymic selection, we interbred rlk–/–itk–/– animals with transgenic mice expressing TCRs directed against either the male-specific antigen HY (HY; reference 10) or a peptide from pigeon cytochrome c (AND; reference 11). Expression of these transgenes allows examination of positive selection processes in the CD8 and the CD4 lineages, respectively. Furthermore, the HY model allows evaluation of both positive and negative selection.
Thymocytes bearing the AND TCR transgene are positively selected in the I-Ab background, showing large numbers of CD4+ cells that express the V11 TCR chain 11. In WT AND+ mice, virtually all mature SP cells are CD4+ and express V11. rlk–/–AND+ mice exhibited varying degrees of subtle defects in this selection process, as indicated by slight reductions in thymic cellularity and absolute numbers of V11 CD4+ SP cells (Fig. 2 and Table ). Deficiency of Itk, however, clearly decreased positive selection, with a marked reduction of V11 CD4 SP cells selected and increased numbers of double-negative and immature CD8 precursor cells (Fig. 2 and Table ) 8. Similarly, we observed a more severe decrease in positive selection with greater reductions of CD4+ cells in mice deficient in both Rlk and Itk. Thus, positive selection in the CD4 lineage with this TCR is most severely impaired in the rlk–/–itk–/– mice.
|
|
chain confirmed that positive selection was most severely decreased in the double knockouts, even more significantly than in itk–/–rlk+/– heterozygous mice (Fig. 3 B).
|
|
10-fold 10. In this system, negative selection was not affected by the lack of Rlk. Although it has been previously reported that negative selection is not significantly impaired by deficiency of Itk 8, we observed varying degrees of defects in negative selection in itk–/– animals (Fig. 4 A). However, we observed marked effects on negative selection resulting from deficiency of both kinases, with a significant increase in DP and CD8+ SP cells in rlk–/–itk–/– mice (Fig. 4 A).
|
Decreased In Vitro Deletion of Thymocytes.
To further examine negative selection, we used an in vitro model of thymocyte deletion induced by plate-bound anti-CD3 and -CD28 antibodies, a strong stimulus that has been shown to drive apoptosis in the majority of DP thymocytes in culture 12. As shown in Fig. 5 A, cell death induced by anti-CD3 plus anti-CD28 was decreased in rlk–/–itk–/– cells, consistent with our in vivo observations using the HY model.
|
To determine whether this CD4+ population resulted from proliferation of mature CD4+ SP cells, we enriched for CD4+CD8+ DP cell by panning with anti-CD8 and performed similar experiments. In this cell population, we again saw decreased cell death in the rlk–/–itk–/– cells, as apparent both by the percentage PI+ cells and the absolute number of viable DP cells (Fig. 5 C). Intermediate defects were observed in cells from rlk–/– and itk–/– mice. In contrast, neither dexamethasone- (data not shown) nor anti-Fas–mediated cell death were reduced in thymocytes from the Tec-deficient mice, arguing that the decreased cell death results specifically from defects in TCR/CD28-mediated responses. Furthermore, we also observed a striking increase in absolute numbers of CD4+ cells present after 24-h stimulation with anti-CD3 and anti-CD28 (Fig. 5C and Fig. D). For itk–/– cells, CD4 levels remained relatively low, whereas in the rlk–/–itk–/– cells, CD4 levels were increased. This population of CD4 cells exhibited higher levels of /β TCR than DP cells but lower than CD4 SP cells from ex vivo thymi (Fig. 5 E). Similarly, these CD4 cells had not fully downregulated the immature cell marker HSA but were lower in HSA than DP cells (data not shown). The intermediate levels of TCR, CD4, and HSA are suggestive of a CD4+CD8lo stage previously described as a precursor population to both CD4+ and CD8+ SP cells 13 and is reminiscent of that seen in an in vitro assay for thymocyte differentiation 14. The phenotype of these CD4+ cells is therefore suggestive of progression of DP to an intermediate pre-SP stage rather than proliferation of an already mature SP CD4+ population. The novel appearance of this CD4 cell population was particularly pronounced in the double knockouts, again suggesting a switch from deletion to a developmental pathway. Thus, a signal that would normally induce death appears to induce survival and differentiation of rlk–/–itk–/– thymocytes.
Biochemical Defects in rlk–/–itk–/– Mice.
To evaluate the nature of the defects in the rlk–/–itk–/– thymocytes, we examined signaling events downstream of TCR engagement. Although modest delays in tyrosine phosphorylation of proteins can be observed after anti-CD3 stimulation, total phosphotyrosine patterns were grossly normal (Fig. 6 A). We have previously reported that tyrosine phosphorylation of TCR chain and ZAP-70 was normal in CD3-stimulated mature cells, indicating normal early tyrosine phosphorylation events 7. Similarly, tyrosine phosphorylation of chain and Zap-70 were grossly intact in thymocytes activated with anti-CD3
(data not shown).
|
1718, which cleaves phosphoinositide 4,5-bisphosphate to diacylglycerol, which activates protein kinase C family members, and inositol triphosphate, which binds to receptors on intracellular organelles, inducing the release of intracellular Ca2+ stores and the subsequent activation of capacitive Ca2+ influx from extracellular sources 19. Consistent with the defective Ca2+ responses in rlk–/–itk–/– thymocytes, we also observed mild defects in tyrosine phosphorylation of PLC-1 after stimulation with antibodies to CD3 (Fig. 6 C).
Recently, Tec family kinases have been implicated as part of complexes nucleated by the adaptor molecules linker of activated T cells (LAT) and Src homology 2 domain–containing lymphocyte protein of 76 kD (SLP-76) that are required for activation of PLC- and Ca2+ mobilization (Fig. 7 A; references 2021222324). To examine how deficiency of Tec kinases affects other components of this signaling complex, we looked at the tyrosine phosphorylation of LAT and other GRB-2–associated molecules including SLP-76 and Cbl 2526. Again, we observed normal patterns of tyrosine phosphorylation with only modest delays in tyrosine phosphorylation of GRB-2–associated proteins (Fig. 7b and Fig. c). Similarly, tyrosine phosphorylation of Vav, another molecule recruited into this complex 27, was also intact. These data suggest that although Tec kinases contribute to these complexes, phosphorylation and assembly of components of these complexes can occur independently of Tec family kinases.
|
and Tec family kinase complexes are thought to be critical determinants of both Ca2+ mobilization and activation of the MAP kinases (MAPKs) ERK 1 and 2 7212324. Because ERK signaling has been shown to influence CD4 and CD8 lineage commitment 2829 and both itk–/– and rlk–/–itk–/– mice exhibit altered CD4/CD8 ratios, we examined whether defects in ERK activation existed in thymocytes from these mice. We observed a reproducible decrease in ERK activation in response to anti-CD3 stimulation in both itk–/– and rlk–/–itk–/– thymocytes (Fig. 7 D), consistent with the decreased number of CD4 SP cells present in these mice. In contrast, activation of p38, a MAPK shown to influence negative selection 3, appears relatively normal in thymocytes from these mice (Fig. 7 D), suggesting that activation of this MAPK is independent of PLC- activation. |
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
It is not clear whether distinct signals mediate positive and negative selection in the thymus. For example, alteration of the MAPK pathway by expression of dominant-negative mutants of Ras and MEKK can alter positive selection with minimal effects on negative selection, whereas interference with p38 or Jun NH2-terminal kinase activation inhibits negative selection 23. One interpretation of our data is that Rlk contributes a specific signal required for negative selection, either downstream of the TCR or from coreceptors such as CD28. Although we have not seen evidence of this in the rlk–/– mice, either in HY male mice or in an in vitro model of deletion using anti-CD3 and CD28 antibodies, it is also possible that this phenotype may only be revealed in the context of Itk deficiency.
Alternatively, regulation of positive and negative selection may not require distinct signals but rather the same signals operating at different intensities 1. Negative selection may therefore involve the same biochemical intermediates as positive selection but require a stronger or more prolonged signal through the TCR and may be less sensitive to small perturbations in signaling. By this model, slight defects in TCR signaling could minimally affect positive selection while not impairing negative selection. Moderate defects in TCR signaling, as in the itk–/– mice, could alter positive selection in the AND and HY models but have a less severe effect on negative selection. The more profoundly impaired TCR signaling in rlk–/–itk–/– double knockouts, as demonstrated by their defect in Ca2+ mobilization (Fig. 6), may not only more severely affect positive selection but also impact negative selection. Similar phenotypes are observed in mice with mutations of the chain of the TCR 3031. The graded nature of the defects we observe in positive and negative selection suggests that these processes may be part of a continuum, consistent with a quantitative view of thymic selection processes. It should be noted, however, that these quantitative differences may be translated into differential activation of downstream molecules, perhaps accounting for data supporting both models of selection.
Although we cannot rule out other effects resulting from elimination of both Rlk and Itk, particularly effects on other signaling pathways, our data suggests that diminished TCR signaling can in fact lead to a paradoxical increase in thymic cellularity in rlk–/–itk–/– mice compared with itk–/– mice due to decreased negative selection. This increased cellularity has additional implications for the relative numbers of cells undergoing negative selection in the thymus. Estimates of cells undergoing negative selection have varied widely depending on the system used to examine this question 3233343536. Our results suggest that defects in this process can significantly influence cell number and lead to increased thymic cellularity.
The development of cells that would normally be deleted, as in the rlk–/–itk–/– HY+ male mice, also suggests that reduction of signal may lead to the development of autoreactive cells, a process that may contribute to the development of autoimmunity in immunocompromised hosts. Nonetheless, the potentially self-reactive cells that develop in young male rlk–/–itk–/–HY+ mice respond poorly to self HY antigen and do not show evidence of activation markers, including CD69 and CD25 (data not shown), consistent with the cellular and biochemical defects we observe in mature cells. Indeed, in order for these cells to proliferate in vitro, addition of exogenous peptide was required. This decreased reactivity may account for a lack of obvious signs of autoimmunity in these animals. Whether the activity of these escaped self-reactive cells may be altered under certain conditions, leading to an autoimmune response, remains an interesting question for future exploration. Notably, a high percentage of T cells from itk–/– and, even more so, rlk–/–itk–/– mice express memory cell markers (Schaeffer, E.M., C. Broussard, and P.L. Schwartzberg, unpublished observations). It is interesting to speculate that these memory cells might result from tonic stimulation of TCRs that recognize self-antigens.
Biochemically, the defects we observe are consistent with an emerging picture of Tec family kinases as a component of a signaling complex including LAT and SLP-76 that is required for full PLC- activation, Ca2+ mobilization, and ERK activation 7152022. Both SLP-76 and LAT have recently been shown to bind to Itk in an inducible fashion, thereby providing a mechanism for recruiting Tec family kinases into this complex 2022. In peripheral cells, the Tec kinases have been implicated in the phosphorylation and activation of PLC-. Our biochemical data suggests that, in thymocytes, Tec family kinases are also required for full Ca2+ mobilization and MAPK activation downstream of PLC- 715373839. However, the relatively normal tyrosine phosphorylation of LAT and the other GRB-2–associated molecules including SLP-76 and Cbl suggest that, unlike the more proximal components, the Tec kinases are probably not required to initiate formation of this complex. It is notable that we have observed mild kinetic delays in tyrosine phosphorylation of components of this complex. Thus, we cannot rule out the possibility that Tec kinases either may contribute to these phosphorylation events or alternatively may be important for the integrity of this Src homology 2–mediated complex. The recent observation that Rlk can phosphorylate SLP-76 supports this notion 40.
Mutation of these kinases, therefore, gives rise to biochemical defects similar to but less severe than that seen in LAT- or SLP-76–deficient cells 2123. Thus, mutation of the Tec kinases, unlike that of the more proximal tyrosine kinases or the more proximal components of the Ca2+ complex, does not eliminate downstream signaling nor prevent T cell development but merely changes the character or duration of the signal, leading to altered thresholds for selection. This altered selection in response to signaling defects is reminiscent of that observed with altered peptide ligands (APLs) with reduced TCR activation 414243. Thus, just as activation of a TCR by APLs permits development of thymocytes 44, mutation of the Tec kinases can permit development of cells that might normally be deleted. Proper activation of the Tec kinases may therefore be critical for helping determine selection processes in the thymus.
The defects we observe in Ca2+ mobilization are consistent with a role for Tec kinases in regulating capacitive Ca2+ entry 45. Inclusion of EGTA generates Ca2+ mobilization profiles that are not significantly different than those of WT cells, suggesting that other molecules contribute to the initial activation of PLC-, particularly in thymocytes. These results are similar to those observed in B lymphocytes from XLA patients where altered PLC- activation lead to defects that are most pronounced in the late phases of capacitive Ca2+ entry 37. Although mutation of rlk itself does not lead to significant phenotypes, mutation of this gene substantially worsens the itk–/– phenotype 7, and overexpression of Rlk/Txk can partially compensate for the lack of Itk 4647, suggesting potential redundancy between these two Tec kinases in T cells. Thus, as in Btk-deficient B lymphocytes, the Tec kinases Itk and Rlk together appear essential for regulating the full activation of PLC-–mediated pathways required for capacitive Ca2+ entry in thymocytes.
In lymphocytes, data suggest that PLC- also contributes to the activation of ERKs in response to antigen receptor stimulation by a protein kinase C (PKC)-mediated activation of Ras and Raf, in addition to the well established GRB-2–son of sevenless (SOS) pathway 4849. Despite the relative integrity of GRB-2–associated proteins in itk–/– and rlk–/–itk–/– cells, we observe a defect in ERK activation. Thus, this defective ERK activation may result from defects in a PLC–PKC- dependent pathway. It is notable that we do not observe defect in activation of p38 in these cells, despite defects in negative selection. Thus, p38 activation may be independent of PLC- activation and probably does not contribute to the defects in negative selection observed in rlk–/–itk–/– mice.
Our observed defect in ERK activation is particularly intriguing given the decreased CD4/CD8 ratio observed in itk–/– and rlk–/–itk–/– mice. The factors that affect lineage decision commitment between CD4 and CD8 cells remain controversial 5051. Again, at least one model suggests that alterations in signaling intensity can help determine this lineage determination, with development of CD4+ cells requiring a stronger signal. However, several specific molecules have also been implicated in the regulation of this cell fate decision, including Notch 52, Lck 5354, and the MAPKs ERK 1 and 2 2829. It is possible that these molecules may contribute to lineage determination by influencing signal intensity or duration or by permitting survival of cells that would normally die due to low signaling. Our data is consistent with that from studies by Bommhardt et al 28 and Sharp et al. 29, who demonstrate that decreased activation of ERKs can alter the lineage decision between CD4+ and CD8+ cells. As both itk–/– and the rlk–/–itk–/– cells exhibit decreased activation of ERK 1 and 2 as a consequence of their defects in signaling downstream from the TCR (Fig. 7), the decreased CD4+ cell number and relative increase in CD8+ cells in both these strains is consistent with previous results using either MEKK inhibitors or a hypersensitive mutant of ERK 2. These data suggest that diminished signaling from the TCR can influence lineage commitment, perhaps by affecting activation of specific downstream molecules, and directly implicate Tec kinases as part of the signaling pathways influencing this decision.
These studies provide further insight into the biochemical intermediates that influence cell fate decisions in the thymus and contribute to the development of the T cell repertoire. Specifically, these data provide evidence that the Tec kinases contribute to setting thresholds required for thymic selection and lineage commitment by controlling activation of downstream signaling molecules. Thus, proper activation of Tec family kinases may be critical for thymocyte selection decisions. In particular, the switch from negative selection to positive selection and the increased thymic cellularity in the rlk–/–itk–/– animals highlights the complex nature of thymic selection, where reduction of TCR signaling may not merely decrease selection but may alter selection and lineage decisions. How defects in these signaling pathways influence these developmental selection decisions may be further delineated through the generation of knockout mice deficient in all three Tec kinases expressed in T cells and the use of different TCR-transgenic mice with varying affinities and avidities of TCR engagement.
|
Acknowledgments |
|---|
E.M. Schaeffer and J. Debnath were Howard Hughes Medical Institute–National Institutes of Health Research Scholars. P. Schwartzberg is supported in part with funds from the Searle Scholars' Program/Chicago Community Trust.
Submitted: 16 May 2000
Revised: 19 July 2000
Accepted: 9 August 2000
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Sebzda E., Mariathasan S., Ohteki T., Jones R., Bachmann M.F. & Ohashi P.S.. Selection of the T cell repertoire, Annu. Rev. Immunol., 17, 1999, 829–874.[Medline]
Alberola-Ila J., Hogquist K.A., Swan K.A., Bevan M.J. & Perlmutter R.M.. Positive and negative selection invoke distinct signaling pathways, J. Exp. Med., 184, 1996, 9–18.
Sugawara T., Moriguchi T., Nishida E. & Takahama Y.. Differential roles of ERK and p38 MAP kinase pathways in positive and negative selection of T lymphocytes, Immunity., 9, 1998, 565–574.[Medline]
Mano H.. Tec family of protein-tyrosine kinasesan overview of their structure and function, Cytokine Growth Factor Rev., 10, 1999, 267–280.[Medline]
Satterthwaite A.B., Li Z. & Witte O.N.. Btk function in B cell development and response, Semin. Immunol., 10, 1998, 309–316.[Medline]
Vihinen M., Mattsson P.T. & Smith C.I.E.. BTK, the tyrosine kinase affected in X-linked agammaglobulinemia, Front Biosci., 2, 1997, d27–42.[Medline]
Schaeffer E.M., Debnath J., Yap G., McVicar D., Liao X.C., Littman D.R., Sher A., Varmus H.E., Lenardo M.J. & Schwartzberg P.L.. Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunity, Science., 284, 1999, 638–641.
Liao X.C. & Littman D.R.. Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk, Immunity., 3, 1995, 757–769.[Medline]
Azzam H.S., Grinberg A., Lui K., Shen H., Shores E.W. & Love P.E.. CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity, J. Exp. Med., 188, 1998, 2301–2311.
von Boehmer H.. Developmental biology of T cells in T-cell transgenic mice, Annu. Rev. Immunol., 8, 1990, 531–556.[Medline]
Kaye J., Hsu M.L., Sauron M.E., Jameson S.C., Gascoigne N.R. & Hedrick S.M.. Selective development of CD4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptor, Nature., 341, 1989, 746–749.[Medline]
Punt J.A., Osborne B.A., Takahama Y., Sharrow S.O. & Singer A.. Negative selection of CD4+CD8+ thymocytes by T cell receptor-–induced apoptosis requires a costimulatory signal that can be provided by CD28, J. Exp. Med., 179, 1994, 709–713.
Lucas B. & Germain R.N.. Unexpectedly complex regulation of CD4/CD8 coreceptor expression supports a revised model for CD4+CD8+ thymocyte differentiation, Immunity., 5, 1996, 461–477.[Medline]
Cibotti R., Punt J.A., Dash K.S., Sharrow S.O. & Singer A.. Surface molecules that drive T cell development in vitro in the absence of thymic epithelium and in the absence of lineage-specific signals, Immunity., 6, 1997, 245–255.[Medline]
Liu K.Q., Bunnell S.C., Gurniak C.B. & Berg L.J.. T cell receptor-initiated calcium release is uncoupled from capacitative calcium entry in Itk-deficient T cells, J. Exp. Med., 187, 1998, 1721–1727.
Thastrup O., Cullen P.J., Drobak B.K., Hanley M.R. & Dawson A.P.. Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase, Proc. Natl. Acad. Sci. USA., 87, 1990, 2466–2470.
Noh D.Y., Shin S.H. & Rhee S.G.. Phosphoinositide-specific phospholipase C and mitogenic signaling, Biochim. Biophys. Acta., 1242, 1995, 99–113.[Medline]
Weiss A., Koretzky G., Schatzman R.C. & Kadlecek T.. Functional activation of the T-cell antigen receptor induces tyrosine phosphorylation of phospholipase C-gamma 1, Proc. Natl. Acad. Sci. USA., 88, 1991, 5484–5488.
Cardenas M.E. & Heitman J.. Role of calcium in T-lymphocyte activation, Adv. Second Messenger Phosphoprotein Res., 30, 1995, 281–298.[Medline]
Bunnell S., Diehn M., Yaffe M., Findell P., Cantley L. & Berg L.. Biochemical interactions integrating Itk with the T cell receptor-initiated signaling cascade, J. Biol. Chem., 276, 2000, 2219–2230.[Medline]
Finco T.S., Kadlecek T., Zhang W., Samelson L.E. & Weiss A.. LAT is required for TCR-mediated activation of PLCgamma1 and the Ras pathway, Immunity., 9, 1998, 617–626.[Medline]
Shan X. & Wange R.L.. Itk/Emt/Tsk activation in response to CD3 cross-linking in Jurkat T cells requires ZAP-70 and Lat and is independent of membrane recruitment, J. Biol. Chem., 274, 1999, 29323–29330.
Yablonski D., Kuhne M.R., Kadlecek T. & Weiss A.. Uncoupling of nonreceptor tyrosine kinases from PLC-gamma1 in an SLP-76- deficient T cell, Science., 281, 1998, 413–416.
Zhang W., Sloan-Lancaster J., Kitchen J., Trible R.P. & Samelson L.E.. LATthe ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation, Cell., 92, 1998, 83–92.[Medline]
Buday L., Egan S.E., Rodriguez Viciana P., Cantrell D.A. & Downward J.. A complex of Grb2 adaptor protein, Sos exchange factor, and a 36-kDa membrane-bound tyrosine phosphoprotein is implicated in ras activation in T cells, J. Biol. Chem., 269, 1994, 9019–9023.
Motto D.G., Ross S.E., Jackman J.K., Sun Q., Olson A.L., Findell P.R. & Koretzky G.A.. In vivo association of Grb2 with pp116, a substrate of the T cell antigen receptor-activated protein tyrosine kinase, J. Biol. Chem., 269, 1994, 21608–21613.
Wu J., Motto D.G., Koretzky G.A. & Weiss A.. Vav and SLP-76 interact and functionally cooperate in IL-2 gene activation, Immunity., 4, 1996, 593–602.[Medline]
Bommhardt U., Basson M.A., Krummrei U. & Zamoyska R.. Activation of the extracellular signal-related kinase/mitogen-activated protein kinase pathway discriminates CD4 versus CD8 lineage commitment in the thymus, J. Immunol., 163, 1999, 715–722.
Sharp L.L., Schwarz D.A., Bott C.M., Marshall C.J. & Hedrick S.M.. The influence of the MAPK pathway on T cell lineage commitment, Immunity., 7, 1997, 609–618.[Medline]
Shores E.W., Tran T., Grinberg A., Sommers C.L., Shen H. & Love P.E.. Role of the multiple T cell receptor (TCR)- chain signaling motifs in selection of the T cell repertoire, J. Exp. Med., 185, 1997, 893–900.[Medline]
Yamazaki T., Arase H., Ono S., Ohno H., Watanabe H. & Saito T.. A shift from negative to positive selection of autoreactive T cells by the reduced level of TCR signal in TCR-transgenic CD3 zeta-deficient mice, J. Immunol., 158, 1997, 1634–1640.[Abstract]
Laufer T.M., DeKoning J., Markowitz J.S., Lo D. & Glimcher L.H.. Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex, Nature., 383, 1996, 81–85.[Medline]
Merkenschlager M., Graf D., Lovatt M., Bommhardt U., Zamoyska R. & Fisher A.G.. How many thymocytes audition for selection?, J. Exp. Med., 186, 1997, 1149–1158.
Ignatowicz L., Rees W., Pacholczyk R., Ignatowicz H., Kushnir E., Kappler J. & Marrack P.. T cells can be activated by peptides that are unrelated in sequence to their selecting peptide, Immunity., 7, 1997, 179–186.[Medline]
Surh C.D., Lee D.S., Fung-Leung W.P., Karlsson L. & Sprent J.. Thymic selection by a single MHC/peptide ligand produces a semidiverse repertoire of CD4+ T cells, Immunity., 7, 1997, 209–219.[Medline]
van Meerwijk J.P., Marguerat S., Lees R.K., Germain R.N., Fowlkes B.J. & MacDonald H.R.. Quantitative impact of thymic clonal deletion on the T cell repertoire, J. Exp. Med., 185, 1997, 377–383.
Fluckiger A.C., Li Z., Kato R.M., Wahl M.I., Ochs H.D., Longnecker R., Kinet J.P., Witte O.N., Scharenberg A.M. & Rawlings D.J.. Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation, EMBO (Eur. Mol. Biol. Organ.) J., 17, 1998, 1973–1985.[Medline]
Scharenberg A.M., El-Hillal O., Fruman D.A., Beitz L.O., Li Z., Lin S., Gout I., Cantley L.C., Rawlings D.J. & Kinet J.P.. Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathwaya target for SHIP-mediated inhibitory signals, EMBO (Eur. Mol. Biol. Organ.) J., 17, 1998, 1961–1972.[Medline]
Takata M. & Kurosaki T.. A role for Bruton's tyrosine kinase in B cell antigen receptor–mediated activation of phospholipase C-gamma 2, J. Exp. Med., 184, 1996, 31–40.
Schneider H., Guerette B., Guntermann C. & Rudd C.E.. Resting lymphocyte kinase (Rlk/Txk) targets lymphoid adaptor SLP-76 in the cooperative activation of interleukin-2 transcription in T-cells, J. Biol. Chem., 275, 2000, 3835–3840.
Madrenas J. & Germain R.N.. Variant TCR ligandsnew insights into the molecular basis of antigen-dependent signal transduction and T-cell activation, Semin. Immunol., 8, 1996, 83–101.[Medline]
Sloan-Lancaster J. & Allen P.M.. Altered peptide ligand-induced partial T cell activationmolecular mechanisms and role in T cell biology, Annu. Rev. Immunol., 14, 1996, 1–27.[Medline]
Smyth L.A., Williams O., Huby R.D., Norton T., Acuto O., Ley S.C. & Kioussis D.. Altered peptide ligands induce quantitatively but not qualitatively different intracellular signals in primary thymocytes, Proc. Natl. Acad. Sci. USA., 95, 1998, 8193–8198.
Hogquist K.A., Jameson S.C., Heath W.R., Howard J.L., Bevan M.J. & Carbone F.R.. T cell receptor antagonist peptides induce positive selection, Cell., 76, 1994, 17–27.[Medline]
Scharenberg A.M. & Kinet J.P.. PtdIns-3,4,5-P3a regulatory nexus between tyrosine kinases and sustained calcium signals, Cell., 94, 1998, 5–8.[Medline]
Sommers C.L., Rabin R.L., Grinberg A., Tsay H.C., Farber J. & Love P.E.. A role for the Tec family tyrosine kinase Txk in T cell activation and thymocyte selection, J. Exp. Med., 190, 1999, 1427–1438.[Medline]
Tomlinson M.G., Kurosaki T., Berson A.E., Fujii G.H., Johnston J.A. & Bolen J.B.. Reconstitution of Btk signaling by the atypical Tec family tyrosine kinases Bmx and Txk, J. Biol. Chem., 274, 1999, 13577–13585.
Sozeri O., Vollmer K., Liyanage M., Frith D., Kour G., Mark G.E. III & Stabel S.. Activation of the c-Raf protein kinase by protein kinase C phosphorylation, Oncogene., 7, 1992, 2259–2262.[Medline]
Kolch W., Heidecker G., Kochs G., Hummel R., Vahidi H., Mischak H., Finkenzeller G., Marme D. & Rapp U.R.. Protein kinase C alpha activates RAF-1 by direct phosphorylation, Nature., 364, 1993, 249–252.[Medline]
von Boehmer H.. CD4/CD8 lineage commitmentback to instruction?, J. Exp. Med., 183, 1996, 713–715.
Robey E. & Fowlkes B.J.. Selective events in T cell development, Annu. Rev. Immunol., 12, 1994, 675–705.[Medline]
Robey E.. Regulation of T cell fate by Notch, Annu. Rev. Immunol., 17, 1999, 283–295.[Medline]
Hernández-Hoyos G., Sohn S.J., Rothenberg E.V. & Alberola-Ila J.. Lck activity controls CD4/CD8 T cell lineage commitment, Immunity., 12, 2000, 313–322.[Medline]
Matechak E.O., Killeen N., Hedrick S.M. & Fowlkes B.J.. MHC class II-specific T cells can develop in the CD8 lineage when CD4 is absent, Immunity., 4, 1996, 337–347.[Medline]
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| TABLE OF CONTENTS |
|
